eFFECTOR Therapeutics- Warrants (26/08/2026) Other Current Liabilities

As of the most recent data (June 2026), EFTRW shows a other current liabilities of $340K. That compares with $7.6M in the prior-year period — down 95.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EFTRW's other current liabilities is now $340K (was $7.6M) — a 95.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether eFFECTOR Therapeutics- Warrants (26/08/2026) is outperforming or lagging.

Tracking EFTRW's other current liabilities over time shows whether eFFECTOR Therapeutics- Warrants (26/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $340K That compares with $7.6M in the prior-year period — down 95.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has eFFECTOR Therapeutics- Warrants (26/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $340K) with ownership activity and broader fundamentals.

eFFECTOR Therapeutics- Warrants (26/08/2026)'s other current liabilities is $340K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.